Development and validation of a UPLC-MS/MS method for the determination of cucurbitacin B in rat plasma and application to a pharmacokinetic study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and validation of a UPLC-MS/MS method for the determination of cucurbitacin B in rat plasma and application to a pharmacokinetic study
Authors
Keywords
-
Journal
BIOMEDICAL CHROMATOGRAPHY
Volume 30, Issue 4, Pages 503-507
Publisher
Wiley
Online
2015-07-24
DOI
10.1002/bmc.3571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitory effect of cucurbitacin B on imiquimod-induced skin inflammation
- (2015) Zheng Jun Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of Cucurbitacin E, a Tetracyclic Triterpene Compound fromCucurbitaceae, on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats
- (2014) Tonggui Ding et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth
- (2014) Yajuan Gao et al. CANCER LETTERS
- Development and validation of an LC-ESI-MS/MS method for the quantitation of hemslecin A in rhesus monkey plasma and its application in pharmacokinetics
- (2013) Min Bai et al. BIOMEDICAL CHROMATOGRAPHY
- Liquid chromatography-tandem mass spectrometric assay for the determination of tetrabenazine and its active metabolites in human plasma: a pharmacokinetic study
- (2013) Venkata Ramu Derangula et al. BIOMEDICAL CHROMATOGRAPHY
- Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets
- (2013) Hina Kausar et al. CANCER LETTERS
- Phytochemical and therapeutic potential of cucumber
- (2012) Pulok K. Mukherjee et al. FITOTERAPIA
- The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer
- (2012) Ahmed Aribi et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
- (2011) Dhong Hyun Lee et al. CANCER LETTERS
- Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways
- (2011) Xueying Zhou et al. HEPATOLOGY RESEARCH
- Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus
- (2011) Sumana Dakeng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration
- (2010) Kin Tak Chan et al. CANCER LETTERS
- Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
- (2010) Tingyan Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562
- (2009) Kin Tak Chan et al. CANCER LETTERS
- Cucurbitacin B induces G2arrest and apoptosisviaa reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells
- (2009) Shusuke Yasuda et al. MOLECULAR NUTRITION & FOOD RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started